SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-059003
Filing Date
2021-04-30
Accepted
2021-04-30 16:07:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2114619d1_defa14a.htm DEFA14A 18883
2 GRAPHIC tm2114619d1_defa14aimg001.jpg GRAPHIC 160280
3 GRAPHIC tm2114619d1_defa14aimg002.jpg GRAPHIC 359411
  Complete submission text file 0001104659-21-059003.txt   736020
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36672 | Film No.: 21877931
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences